WO2008082369A2 - Utilisation d'une coenzyme q10 à des fins de rentabilité d'élevage et de production de tissus animaux renfermant ladite coenzyme en concentration élevée - Google Patents
Utilisation d'une coenzyme q10 à des fins de rentabilité d'élevage et de production de tissus animaux renfermant ladite coenzyme en concentration élevée Download PDFInfo
- Publication number
- WO2008082369A2 WO2008082369A2 PCT/SI2007/000040 SI2007000040W WO2008082369A2 WO 2008082369 A2 WO2008082369 A2 WO 2008082369A2 SI 2007000040 W SI2007000040 W SI 2007000040W WO 2008082369 A2 WO2008082369 A2 WO 2008082369A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coenzyme
- animal
- animals
- coqio
- feed
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 124
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims abstract description 88
- 230000001965 increasing effect Effects 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 239000005515 coenzyme Substances 0.000 title description 6
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 83
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 82
- 235000013372 meat Nutrition 0.000 claims abstract description 68
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 48
- 238000003307 slaughter Methods 0.000 claims abstract description 37
- 230000003698 anagen phase Effects 0.000 claims abstract description 15
- 230000037396 body weight Effects 0.000 claims abstract description 11
- 239000013589 supplement Substances 0.000 claims abstract description 11
- 235000013361 beverage Nutrition 0.000 claims abstract description 9
- 244000144977 poultry Species 0.000 claims abstract description 9
- 235000013601 eggs Nutrition 0.000 claims abstract description 8
- 235000013365 dairy product Nutrition 0.000 claims abstract description 5
- 235000013336 milk Nutrition 0.000 claims abstract description 5
- 239000008267 milk Substances 0.000 claims abstract description 5
- 210000004080 milk Anatomy 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 4
- 108090000790 Enzymes Proteins 0.000 claims abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 114
- 235000012000 cholesterol Nutrition 0.000 claims description 57
- 239000003925 fat Substances 0.000 claims description 47
- 239000000047 product Substances 0.000 claims description 22
- 241000282414 Homo sapiens Species 0.000 claims description 15
- 230000012010 growth Effects 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 7
- 241000283690 Bos taurus Species 0.000 claims description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
- 235000019728 animal nutrition Nutrition 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007972 injectable composition Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 241000282887 Suidae Species 0.000 claims description 2
- -1 boluses Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 40
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 43
- 241000287828 Gallus gallus Species 0.000 description 25
- 235000013330 chicken meat Nutrition 0.000 description 25
- 230000036541 health Effects 0.000 description 14
- 235000013622 meat product Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 4
- 235000015250 liver sausages Nutrition 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 210000003032 wing Anatomy 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 2
- 101150113809 COQ10 gene Proteins 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019625 fat content Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- This invention relates to a novel use of coenzyme Q10 in animal husbandry as additive or supplement to animal feed/fodder or animal beverages, and to the enrichment of animal tissues, especially meat with coenzyme Q10.
- a further object of this invention is animal tissue enriched with coenzyme Q10.
- Animal tissues within the scope of this invention are in addition to all types of meat, bones, skins and the like, also poultry eggs and the milk of dairy animals.
- Coenzyme Q10 is a lipophylic, water-insoluble substance that is indispensable for the functioning of the human organism, since it is involved as coenzyme in numerous metabolic processes; it is involved in processes of cell energy formation. It has been known, that the CoQIO quantity in human tissues is proportional to the activity of each tissue. Thus, the highest concentrations were observed in the heart muscle. CoQIO deficiency results in impaired vitality, resistance and the like. On the contrary, sufficient CoQIO quantities improve vitality and resistance, enhance the treatment of various diseases, and alleviate various health troubles.
- 1 kg of chicken meat contains about 6-25 mg of CoQ10/kg, and about 10- 100 g of fats, as well as up to 600 mg of cholesterol/kg; 1 kg of pork or beef contains about 20-35 mg of CoQ10/kg, and about 15-350 g of fats, as well as up to 600-800 mg of cholesterol per kg of meat. It is evident that the CoQIO quantity in the meat is correlated with the quantity of fats and cholesterol. Accordingly, the replenishment of the CoQIO deficiency by consumption of increased quantities of fatter meat that contains a higher amount of CoQIO, is neither a sufficient nor an adequate solution.
- meat contains significant CoQIO amounts that are, however, not sufficient to ensure the consumption of sufficient CoQIO with normal meat quantities.
- This is valid for rather lean meat types or parts, comprising minor amounts of fat, for example chicken meat, especially chicken breasts, containing about 6-10 mg of CoQ10/kg.
- fats and cholesterol render the meat less suitable for healthy alimentation.
- the problem of excess fats and cholesterol contents (and consequently, the inadequate ratio with respect to CoQIO) in meat and in meat products has been solved in various ways, such as elimination of fat from meat by trimming, extraction, and admixing of the products by components other than meat and the like.
- the problem hitherto not adequately solved, is the enrichment of meat with CoQIO, and the improvement of the ratio of CoQIO to fats and cholesterol in meat, in order to -A- increase the amount of CoQIO at the same or reduced content of fats and cholesterol.
- the consumption of such meat would result in the intake of increased quantities of CoQIO, and minimize the need for C0QIO- containing food additives or medicines.
- Another problem, hitherto not adequately solved, is the raising of animals having increased meat mass or weight rate, and improved feed/fodder utilization, with the aid of as few as possible various, possibly natural substances, favorably influencing animal health. All these factors would enhance the profitability of animal husbandry, the production of meat and its quality.
- the task and object of this invention is an economical and simple process for the enrichment of meat of various animals with CoQIO, yielding various kinds of meat with an increased CoQIO content, and an improved ratio of CoQIO to fats and cholesterol, as well as the utilization of such meats and their products for human consumption.
- a further task and object of this invention is a simple method of raising animals with the aid of as few as possible various, possibly natural substances, enabling the increase of animal weight, improved feed/fodder utilization, and consequently the profitability of animal husbandry.
- the animals are chosen from warm-blooded animals, intended for human consumption, such as poultry, small cattle, swine, cattle, rabbits, horses, game and others, especially animals, containing less CoQIO and more cholesterol and fats in their meat or meat parts, and skin.
- the tasks and objects of this invention are simultaneously solved in a surprising and unobvious way, by the addition of CoQIO in a suitable form, either alone or as a feed/fodder component or as a feed/fodder supplement, in liquid or solid form, to animal feed supply, or in other conventional ways, during convenient growth phases, or at a convenient period prior to slaughter.
- the tasks and objects are solved by the use of CoQIO 1 and by a process of administration to the animals or by feeding the animals with convenient CoQ.10 formulations, as well as the utilization of the obtained meat and meat products in accordance with independent claims.
- the gist of invention is a novel use of CoQIO in convenient form for animal feeding, and a process of feeding animals a convenient CoQIO formulation, or a feed/fodder supplemented with CoQIO in convenient form, or with CoQ10-containing nutritional supplements, during suitable growth phases, or at a convenient period prior to slaughter.
- CoQ 10 as sole natural animal feed supplement causes several effects simultaneously, namely the increase of animal weight, the enhancement of feed/fodder utilization, the enrichment of meat with CoQIO, the diminishment of cholesterol and fat contents, and the improvement of the ratio of CoQIO to fats and cholesterol in meats and various tissues. This enables the production of meat products or tissue products, having improved properties for human health and animal health, and the utilization of meat and tissues, as well as products thereof, for health food.
- CoQIO has virtually no negative effects on the organism, nor is it accumulated in excess of a level, acceptable to the organism or single tissue. On the contrary, it has several positive effects on humans and animals. This represents, as one aspect, another advantage in comparison with other growth- enhancing feed/fodder supplements. On the other hand, it ensures to humans and animals not only a completely safe, but also an advantageous consumption of CoQ10-enriched meat and tissues as well as products thereof, according to this invention.
- the invention enables a simple and economical production of functional nutritional products - animal meat and tissues, to say nutritional products exerting positive effect on the health of humans and animals that consume said nutritional products.
- CoQIO is administered to animals in convenient form, for example by the addition of CoQIO to feed/fodder or beverages for consumption, or separately.
- feed/fodder with added convenient CoQIO formulation CoQ10-containing feed/fodder supplements, CoQ10-containing animal beverage supplements, various CoQ10-containing animal nutritional supplements such as hard or soft capsules, tablets, syrups, drops, suspensions, emulsions and other suitable formulations, based on various water-soluble or water-insoluble CoQIO forms.
- the feed/fodder can be natural such as forage (grass, hay), corn, vegetables and the like, or artificial such as various industrially manufactured feeds/fodders.
- CoQIO can be administered by means of injectable formulations, transdermal formulations, implantates, and the like.
- the above-mentioned routes enable the administration of some mg to some 100 mg CoQ10/kg body mass daily, for example 1-500 mg or more, preferably 1-50 mg, more preferably 1-20 mg CoQ10/kg body mass daily, in a single or multiple daily dose.
- the amount is adapted to the growth phase, by increasing daily doses during intensive growth phases. However, during starting animal development phases and during slower growth phases, the dosage is reduced or even discontinued.
- Such a CoQIO dosage regimen results in optimal growth increase and feed/fodder utilization, partially also in optimal CoQIO amounts in animal tissues, and the improvement of the ratio of CoQIO to fats and cholesterol.
- the CoQIO concentration can be significantly increased, and the fats and cholesterol amounts further reduced, by repeated CoQIO dosage or by increasing the doses at a determined period prior to slaughter. If only the increase of the CoQIO amount in tissues, and the enhancement of the ratio to cholesterol and fats, or the decrease of their amounts, is desired, this can only be accomplished by means of increased CoQIO dosage prior to slaughter. Therewith the consumption of CoQIO is optimized, concerning the growth rate efficiency, and meat quality, from the standpoint of CoQIO, fats and cholesterol concentrations, as well as the ratio of CoQIO to fats and cholesterol. This is especially important from the standpoint of profitability.
- the present invention enables a significant weight rate and simultaneously enhances the health adequacy of the obtained meat or animal parts and products thereof, in human and animal nutrition.
- CoQIO dosage There is virtually no upper limit of CoQIO dosage; it depends only on the desired effects.
- the procedure and regimen of CoQIO addition enable to influence the desired effects, either the increase of CoQIO content, and its ratio to cholesterol and fats, or the increase of growth rate, or both.
- the addition of CoQIO during the intensive growth phases increases primarily the growth rate.
- the addition during some weeks or at least some days prior to slaughter increases the CoQIO content in tissues. Both effects - enhanced health adequacy and growth rate - are optimally achieved by the feeding combination during both periods.
- the addition regimen can also influence the relative increase of individual tissues and animal parts.
- Typical examples are broiler chickens, slaughtered on day 42, to say at the completion of intensive growth.
- CoQIO dosage regimen namely 20 days prior to slaughter, on the average 5 mg water-soluble CoQ10/kg body weight, the weight increase amounted to 30% at about 5% lower feed/fodder consumption, in comparison with the control group, which received no CoQIO.
- the total CoQIO concentration was significantly increased, for example doubled in breast meat.
- a minor increase of CoQIO was typical for tissues, which already contained larger amounts of said substance.
- the cholesterol amount in individual tissues was very much diminished, especially in breast meat more than halved.
- the ratio of CoQIO amount to cholesterol amount was more than doubled in individual tissues. A cholesterol reduction of nearly 30% is achieved even in underskin fat tissue. By an appropriate higher dosage these effects can be further improved.
- the CoQIO content in tissues can be increased by gradually increasing the amount of CoQIO.
- increasing gradually the daily dosage during the last 20 days prior to slaughter from 5 mg/kg to 10 mg/kg body weight yields an approx. 25-60 % higher CoQIO content in individual tissues, in comparison with the constant addition of 5 mg/kg body weight.
- Daily administration of 10 mg CoQ10/kg body weight yields an average CoQIO content increase in the meat of about 6-8 mg/kg.
- An increase is also noticed in tissues, where chickens show a minor CoQ10 increase, such as in the heart and thighs. This is the consequence of the general CoQ10 depletion with progressive ageing.
- the cholesterol content in the meat decreases for about 15-20 %, in the heart for about 30 %.
- the CoQIO content in eggs is simultaneously increased; at a dosage of 7 mg CoQ10/kg body weight for about 60-70 %, at a dosage of 10 mg/kg body weight even for about 100 %.
- a CoQIO increase in the meat and the diminishment of fats and cholesterol quantities is achieved by one or two months addition of CoQ10 prior to slaughter; the amount of 15 mg CoQIO increases tissue CoQIO for about 20-60 % (up to about 40 mg/kg), and reduces cholesterol for up to about 50 %.
- a daily dosage of 20 mg CoQ10/kg body weight increases the CoQIO quantity for up to about 75 %, and reduces the cholesterol quantity for up to about 60 %.
- the fat quantity of the meat is diminished for up to about 30 %.
- the objects of this invention are the use and a process for the use of CoQIO in animal husbandry, for improved weight increase, increased CoQIO content and improved ratio of COQ10 to cholesterol and fats in the meat or other animal parts, then the meat and other animal parts with an increased CoQIO content, and said contents ratio, as well as their utilization in human and animal nutrition.
- the essence of the animal raising regimen is the addition of CoQ 10 in a convenient form during the intensive growth phase, especially for growth increasing; during the second half of animal life, for increasing the CoQIO content and diminishing cholesterol and fats contents, or for enhancing their mutual ratio, preferably 3 days to 3 months prior to slaughter.
- the duration of the first addition phase depends on the animal type and lasts for swine about 6 months, for cattle about 18 months, especially the first three months; for chicken about 1.5 months, for rabbits about 3-4 months, similarly for geese and ducks, and so on.
- the administration of CoQIO to animals during the first days of life is of no avail.
- short- living animals such as chickens and broilers, both CoQIO addition phases may overlap.
- the optimal COQ10 addition period from the standpoint of increasing the CoQIO content and its ratio to fats and cholesterol, as well as from the standpoint of growth rate and profitability, is about 20 days prior to slaughter.
- meat and other animal parts are processed according to this invention into dried or undried meat products such as pa " tes, sausages, terrines, mince meat, briquettes, and other products. Obtained are products with an increased CoQIO content and decreased cholesterol and fats contents, or an improved ratio of CoQIO to cholesterol and fats, without the addition of said enzyme during the manufacturing procedure, hence without the aid of CoQIO as supplement to said products, as well as without special elimination of cholesterol and fats.
- the health adequacy of alimentary products of animal origin is significantly improved.
- a further object of this invention are products made of meat parts and other tissues, obtained by raising animals with the aid of added CoQIO, their manufacture and use.
- the invention is illustrated, but in no way limited, by the working Examples. Used were following materials: water-soluble CoQ 10 according to patent SI 21783, WO 2005/111224 A2 (QiOVital, Valens Int., Slovenia), AII-Q (DSM, Netherlands), CoQIO (Daewoong Chemical Co., Korea), feeds BRO-G and BRO-F2 (Perutnina Ptuj d.d., Slovenia), TL-starter and TL-PIT2 (Agrokombinat Maribor, Slovenia). Chickens were bred in Perutnina Ptuj d.d., Slovenia, other animals on private farms.
- a conventional poultry feed was supplemented with CoQIO in the form of an aqueous suspension (7.5 %).
- a premix was prepared, "diluting" at first CoQIO in 30 kg of com meal. Then a corresponding portion of this premix was fed to other raw- materials, into a 60 kg mixer. After stirring were obtained 60 kg of a homogenous feed mixture with a CoQIO concentration of 0.0042 %.
- Chicken feed was admixed with water-soluble CoQIO in water (7.5 %), obtaining a homogenous feed with a CoQIO content of 0.0042 %. Healthy chicken were selected one day after hatching and two separate groups of 25 chickens were put into hencoops. During the complete period prior to slaughter the first group was fed a CoQIO free feed; the second group received the first twenty days an identical feed as the first group, and the second twenty days (prior to slaughter) a CoQ10-supplemented feed. In both groups, the weight, health state and behavior of the animals were observed.
- EXAMPLE 3 Feeding chickens CoQ10-supplemented feed for 30 days prior to slaughter
- Chicken feed was admixed with water-soluble CoQ10 in water (7.5 %), obtaining a homogenous feed with a CoQ10 content of 0.0042 %.
- Healthy chicken were selected one day after hatching and two separate groups of 25 chickens were put into hen-coops. During the whole period prior to slaughter the first group received a CoQ10-free feed; the second group received the first ten days an identical feed as the first group, and the remaining thirty days (prior to slaughter) a C0QIO- supplemented feed. In both groups, the weight, health state and behavior of the animals were controlled.
- EXAMPLE 4 Feeding chickens CoQ10-supplemented feed for 40 days
- Chicken feed was admixed with water-soluble CoQIO in water (7.5 %), obtaining a homogenous feed with a CoQIO content of 0.0042 %.
- Healthy chicken were selected one day after hatching and two separate groups of 25 chickens were put into hencoops. During the whole period prior to slaughter the first group received a CoQIO- free feed; the second group 40 days (prior to slaughter) a CoQ10-supplemented feed. In both groups, the weight, health state and behavior of the animals were observed. After slaughter (on day 42) were determined by means of HPLC-MS and QTLC the concentrations of CoQIO 1 cholesterol and fats in individual chicken parts, namely in the meat of thighs, wings, breasts, hearts, and livers. Analysis results are shown in Table 6 and Table 7.
- Table 7 Comparison of cholesterol content in the group, fed 40 days a feed without CoQIO addition (reference group), with the group, fed with the addition of CoQIO (test group); results are given in m/kg.
- EXAPLE 8 Meat-and-liver pate
- the pate was made of meat and livers of hens, fed the last 20 days prior to slaughter, a feed homogenously supplemented with CoQIO to a concentration of 0.008 %, as in Example 1.
- the hen meat and liver were processed into a pa " te; its CoQ10, fats and cholesterol contents were analyzed. The results were compared with the results of the reference pate. (Table 8).
- Table 10 Comparison of CoQIO, fats and cholesterol contents in the pate made of meat and livers of normal hens, with that of hens, fed the last 20 days prior to slaughter, CoQ10-supplemented feed.
- this invention relates to a use of coenzyme Q10 to improve the effectiveness of animal husbandry, and the production of animal tissues, to say all types of meat, bones, skins and the like, poultry eggs and the milk of dairy animals, with an increased content of said enzyme, wherein the intake of coenzyme Q10 by the animals is performed by consumption or direct administration into or onto the body, and wherein coenzyme Q10 is in a convenient water-soluble or water-insoluble form, preferably in the form of enhanced bioavailability.
- the animals consume the coenzyme Q10 or receive it in another manner during all their lifetime or at a determined period any time during their lifetime, preferably during their growth phase and/or at an optional period prior to slaughter, more preferably during growth phases and/or 3-90 days prior to slaughter.
- the animals consume 1-1000 mg of coenzyme
- Q10 per kg of body weight daily preferably 1-50 mg, more preferably 1-20 mg.
- Coenzyme Q10 is added to the animal feed/fodder or beverage, the feed/fodder being any animal nutrient, unprocessed or processed, natural or artificial or industrially manufactured, respectively.
- Coenzyme Q10 is in the form of convenient solid, semisolid, semiliquid or liquid formulations for the administration to animals, such as capsules, tablets, boluses, granules, powders, syrups, injectable formulations, creams, ointments, implantates and others. The duration of coenzyme
- coenzyme Q10 addition is regulated in conformance with the desired effects, animal type, profitability and the like.
- coenzyme Q10 is administered to animals during the growth period to increase the concentration of coenzyme Q10, and the concentration ratio of coenzyme Q10 to cholesterol and tissue fats, respectively, at a convenient time prior to slaughter.
- the mentioned animals are poultry, small cattle, pigs, rabbits, and other animals, the meat or other parts of which are intended for human or animal consumption.
- Animal tissues, including poultry eggs and milk of dairy animals, according to this invention, are enriched with coenzyme Q10; at the same time, they may contain less cholesterol and fats. Their quantity ratio of coenzyme Q10 to their cholesterol and tissue fats is improved.
- Animal tissue products are intended for human or animal consumption, and contain increased quantities of coenzyme Q10, and less cholesterol and fats; they have an improved quantity ratio of coenzyme Q10 to their cholesterol and tissue fats, respectively.
- Tissues and tissue products are intended for human or animal consumption.
- Feed/fodder and beverages for animals comprise added coenzyme Q 10.
- Feed/fodder supplements comprise added coenzyme
- Formulations for the administration to animals, according to this invention comprise added coenzyme Q10.
- Processes for the manufacture of animal feed/fodder and formulations with coenzyme Q10 are characterized by the addition of coenzyme Q10 during an optional phase of the manufacturing procedure, or by admixing to the pre-prepared feed/fodder or formulations.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RSP-2009/0290A RS20090290A (en) | 2006-12-29 | 2007-11-22 | Use ofcoenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme |
HR20090315A HRP20090315A2 (en) | 2006-12-29 | 2009-05-29 | Use of coenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SIP-200600293 | 2006-12-29 | ||
SI200600293A SI22407A (sl) | 2006-12-29 | 2006-12-29 | Uporaba koencima q10 za uäśinkovitejĺ o vzrejo ĺ˝ivali in pridelavo ĺ˝ivalskih tkiv s poveäśano vsebnostjo tega koencima |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008082369A2 true WO2008082369A2 (fr) | 2008-07-10 |
WO2008082369A3 WO2008082369A3 (fr) | 2008-10-02 |
Family
ID=39561863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SI2007/000040 WO2008082369A2 (fr) | 2006-12-29 | 2007-11-22 | Utilisation d'une coenzyme q10 à des fins de rentabilité d'élevage et de production de tissus animaux renfermant ladite coenzyme en concentration élevée |
Country Status (4)
Country | Link |
---|---|
HR (1) | HRP20090315A2 (fr) |
RS (1) | RS20090290A (fr) |
SI (1) | SI22407A (fr) |
WO (1) | WO2008082369A2 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011206050A (ja) * | 2010-03-09 | 2011-10-20 | Kaneka Corp | 豚用飼料及びその給与方法 |
EP2572589A1 (fr) * | 2010-05-21 | 2013-03-27 | Kaneka Corporation | Nourriture porcine et procédé d'alimentation de porcs |
CN104171647A (zh) * | 2014-07-25 | 2014-12-03 | 许伟琦 | 一种消除宠物体味的饲料添加剂 |
CN106858141A (zh) * | 2017-03-06 | 2017-06-20 | 北京大伟嘉生物技术股份有限公司 | 一种生产富含ω‑3多不饱和脂肪酸和辅酶Q10鸡蛋的饲料 |
CN106962819A (zh) * | 2017-03-06 | 2017-07-21 | 北京大伟嘉生物技术股份有限公司 | 富含ω‑3多不饱和脂肪酸和辅酶Q10的鸡蛋及其制备方法 |
CN112401067A (zh) * | 2020-09-27 | 2021-02-26 | 天津农学院 | 一种提高蛋黄中辅酶q10沉积量的饲料添加剂及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB918409A (en) * | 1960-03-22 | 1963-02-13 | Hoffmann La Roche | Animal feeds |
EP0657103A2 (fr) * | 1993-12-08 | 1995-06-14 | RTA Associates, Inc. | Procédé de maintien de la fraicheur de la viande et du poisson et procédé d'amélioration de la croissance des animaux |
WO2005111224A2 (fr) * | 2004-05-18 | 2005-11-24 | Kemijski Institut | Nouvelle forme hydrosoluble de la coenzyme q10 sous la forme d'un complexe d'inclusion avec de la beta-cyclodextrine, son procede de preparation et ses utilisations |
-
2006
- 2006-12-29 SI SI200600293A patent/SI22407A/sl not_active IP Right Cessation
-
2007
- 2007-11-22 RS RSP-2009/0290A patent/RS20090290A/sr unknown
- 2007-11-22 WO PCT/SI2007/000040 patent/WO2008082369A2/fr active Application Filing
-
2009
- 2009-05-29 HR HR20090315A patent/HRP20090315A2/xx not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB918409A (en) * | 1960-03-22 | 1963-02-13 | Hoffmann La Roche | Animal feeds |
EP0657103A2 (fr) * | 1993-12-08 | 1995-06-14 | RTA Associates, Inc. | Procédé de maintien de la fraicheur de la viande et du poisson et procédé d'amélioration de la croissance des animaux |
WO2005111224A2 (fr) * | 2004-05-18 | 2005-11-24 | Kemijski Institut | Nouvelle forme hydrosoluble de la coenzyme q10 sous la forme d'un complexe d'inclusion avec de la beta-cyclodextrine, son procede de preparation et ses utilisations |
Non-Patent Citations (1)
Title |
---|
BHAGAVAN HEMMI N ET AL: "Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics" FREE RADICAL RESEARCH, vol. 40, no. 5, May 2006 (2006-05), pages 445-453, XP009102744 ISSN: 1071-5762 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011206050A (ja) * | 2010-03-09 | 2011-10-20 | Kaneka Corp | 豚用飼料及びその給与方法 |
EP2572589A1 (fr) * | 2010-05-21 | 2013-03-27 | Kaneka Corporation | Nourriture porcine et procédé d'alimentation de porcs |
EP2572589A4 (fr) * | 2010-05-21 | 2014-04-16 | Kaneka Corp | Nourriture porcine et procédé d'alimentation de porcs |
JP5868848B2 (ja) * | 2010-05-21 | 2016-02-24 | 株式会社カネカ | 豚用飼料及びその給与方法 |
CN104171647A (zh) * | 2014-07-25 | 2014-12-03 | 许伟琦 | 一种消除宠物体味的饲料添加剂 |
CN106858141A (zh) * | 2017-03-06 | 2017-06-20 | 北京大伟嘉生物技术股份有限公司 | 一种生产富含ω‑3多不饱和脂肪酸和辅酶Q10鸡蛋的饲料 |
CN106962819A (zh) * | 2017-03-06 | 2017-07-21 | 北京大伟嘉生物技术股份有限公司 | 富含ω‑3多不饱和脂肪酸和辅酶Q10的鸡蛋及其制备方法 |
CN112401067A (zh) * | 2020-09-27 | 2021-02-26 | 天津农学院 | 一种提高蛋黄中辅酶q10沉积量的饲料添加剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
RS20090290A (en) | 2010-06-30 |
WO2008082369A3 (fr) | 2008-10-02 |
SI22407A (sl) | 2008-06-30 |
HRP20090315A2 (en) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100222279A1 (en) | Composition for animal consumption and method for reducing map kinase activity | |
DK2371226T3 (en) | BILD SALT ADJUSTMENT TO ANIMALS TO IMPROVE THE FAT USE EFFECTIVENESS OF ANIMAL ORGANIZATIONS | |
WO2000049889A1 (fr) | Complement alimentaire pour animaux destine a enrichir d'un point de vue nutritionnel des produits d'origine animale | |
Choct et al. | The effect of dietary selenium source and vitamin E levels on performance of male broilers | |
WO2008082369A2 (fr) | Utilisation d'une coenzyme q10 à des fins de rentabilité d'élevage et de production de tissus animaux renfermant ladite coenzyme en concentration élevée | |
JP2008011731A (ja) | 抗菌性物質を含有しないハーブ入り幼齢子豚用配合飼料 | |
Omenka et al. | Vegetable-based feed formulation on poultry meat quality | |
JP2542655B2 (ja) | 動物用混合飼料 | |
TW200926992A (en) | Agent for improving carcass performance in finishing pigs | |
Burtseva et al. | Productive qualities and quality of large white pigs’ meat using vitamin feed additive | |
EP2817016B1 (fr) | Méthode pour améliorer la qualité de la viande de poulet | |
JP2017534299A (ja) | 牛肉中にオメガ3を高レベルで生成するための、ウシへの低投与量での藻類の給餌 | |
RU2440008C1 (ru) | Способ повышения продуктивности цыплят-бройлеров | |
Wady et al. | Effect of Adding Different Levels of Water Extract of the Pumpkin Leaves and Pumpkin Seeds Powder (Cucurbita moschata) in Some of The Productive Characteristics of Broiler | |
JP3285630B2 (ja) | 鶏用飼料 | |
Korhonen et al. | Effect of carotenoid supplement on production performance in mink (Neovison vison) | |
RU2828426C1 (ru) | Комбикорм для цыплят-бройлеров в первую фазу кормления | |
Dieumou et al. | Growth performance, carcass characteristics and economics of production of broilers fed diets with two sources of protein and two levels of wheat offal | |
CN110446432A (zh) | 用于改进动物的性能参数的方法 | |
Skibsted | Dietary treatment and oxidative stability of muscles and meat products. Nutritive value, sensory quality and safety | |
WO2005039306A2 (fr) | Additif nutritionnel pour animaux, procede de preparation et applications | |
Ulrikh | Feed Additives Production Out of Dairy Industry Waste | |
Mengesha et al. | Fed Selected Energy Source Feeds | |
Prylipko et al. | USE OF AN ENZYME PREPARATION IN THE FEEDING OF MEAT CHICKEN | |
Beg et al. | Maximizing Performance with Safe Meat Production of Broiler by Feeding Enzyme Supplemented Antibiotic Free Diet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07835576 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20090315A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2009/0290 Country of ref document: RS |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07835576 Country of ref document: EP Kind code of ref document: A2 |